Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary N Walsh, MD, MACC
St. Vincent Heart Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital
Garran, Australian Capital Territory, Australia
- John Hunter Hospital
New Lambton Heights, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Sydney Adventist Hospital
Wahroonga, New South Wales, Australia
- the Prince Charles Hospital
Chermside, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Monash Heart
Clayton, Victoria, Australia
- Royal Melbourne Hospital / Royal Hobart Hospital
Parkville, Victoria, Australia
- Fiona Stanley Hospital
Perth, Western Australia, Australia
- Royal Prince Alfred Hospital
Camperdown, Australia
- Chu Grenoble - Hopital Michallon Service de Cardiologie
Grenoble, France
- Centre Cardiologique Du Nord
Paris, France
- Chu-Hopital Pontchaillou
Rennes, France
- Immanuel Klinikum Bernau - Herzzentrum Brandenburg
Bernau, Germany
- Universitätsklinikum Erlangen
Erlangen, Germany
- Universitäres Herzzentrum Hamburg (uke Hamburg) Gmbh (uhz)
Hamburg, Germany
- Policlinico S. Orsola
Bologna, Italy
- Ospedale San Gerardo
Monza, Italy
- Isala Hartcentrum
Zwolle, Netherlands
- Liverpool Heart and Chest Hospital
Liverpool, United Kingdom
- Barts Heart Centre
London, United Kingdom
- St. Thomas Hospital
London, United Kingdom
- Manchester Heart Centre
Manchester, United Kingdom
- James Cook University Hospital
Middlesbrough, United Kingdom
- John Radcliffe Hospital
Oxford, United Kingdom
- Heart Center Research
Huntsville, Alabama, United States
- University of California, San Diego
La Jolla, California, United States
- Broward Health Medical Center
Fort Lauderdale, Florida, United States
- St. Vincent'S Healthcare
Jacksonville, Florida, United States
- Watson Clinic
Lakeland, Florida, United States
- Naples Community Hospital
Naples, Florida, United States
- Northside Hospital and Heart Institute
St. Petersburg, Florida, United States
- Emory Healthcare
Atlanta, Georgia, United States
- Piedmont Heart Institute
Atlanta, Georgia, United States
- Prairie Heart
Springfield, Illinois, United States
- St. Vincent'S Hospital and Healthcare Center
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- Saint Luke'S Health System Kansas City
Kansas City, Kansas, United States
- the University of Kansas Medical Center
Kansas City, Kansas, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jan 2018
- Primary completion
- 30 Jun 2026
- Completion
- 30 Jun 2026
- Last update posted
- 9 Jul 2025
- Registered enrollment
- 300
- Registry id
- NCT02922036
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.